Entrada Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:TRDA) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -50.86 M-93.79 M139.8 M-41.56 M-128.51 M -131.7 M Cash from investing activities -4.58 M-148.65 M-138.4 M-27.8 M116.81 M 139.01 M Cash from financing activities 307.46 M479 K21.04 M102.96 M887 K 637 K Free cash flow -50.86 M-93.79 M139.8 M-41.56 M-129.55 M -131.64 M

News

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates